London, UK, 7 October 2024 – Avillion Life Sciences Ltd (“Avillion”) announces that the ongoing BATURA Phase IIIb trial evaluating…
Drug and biotech companies are seeing significant innovation in 2024. In the Large-Cap Pharmaceuticals industry, Eli Lilly (LLY), AstraZeneca (AZN),…
The FDA grants priority review to AZNs sNDA for Calquence for untreated mantle cell lymphoma. A decision is expected in…
1 October 2024 15:00 BST
Transparency Directive
Voting rights and capital
The following notification is made in accordance with the UK Financial Conduct…
The FDA grants priority review to AZNs sBLA for Enhertu to treat HER2-low or HER2-ultralow metastatic breast cancer. A decision…
European health-care stocks are set to snap their longest winning streak since March 2010, dragged down by concerns over Novo…
Toyota Motor, AstraZeneca, Chubb, Air T and Preformed Line Products are part of the Zacks top Analyst Blog.…
26 September 2024
Tagrisso approved in the US for patients with
unresectable, Stage III EGFR-mutated lung cancer
Based on LAURA Phase III trial results which showed Tagrisso
extended…
The FDA approves AstraZenecas Tagrisso for treating unresectable, stage III EGFR-mutated non-small cell lung cancer.…
AZNs key drugs like Lynparza, Tagrisso, Imfinzi, Ultomiris and Farxiga are likely to drive sales. It has several candidates with…
Todays Research Daily features new research reports on 16 major stocks, including Toyota Motor Corp. (TM), AstraZeneca PLC (AZN) and…
Pfizer, Eli Lilly, AstraZeneca, Bayer and Sanofi can prove to be great additions to your portfolio.…
…
1. Rightmove receives third bid from genuinely disappointed REA Group This marks the third approach made by REA, following an…
23 September 2024
Datopotamab deruxtecan final overall survival results reported in
patients with metastatic HR-positive, HER2-low or negative breast cancer in
TROPION-Breast01 Phase…
US FDA approves AstraZenecas flu vaccine for self-administration…
FDA approves Lillys eczema drug, Ebglyss, and the expanded use of Novartis Kisqali, Mercks Keytruda and AstraZenecas Fasenra.…
BenevolentAI (OTC:BAIVF), the AI-driven biopharma drug discovery working with the likes of AstraZeneca and Merck, today announced its interim results…
Thermo Fisher Scientific will expand its bioanalytical presence in Europe and has chosen Gothenburg, Sweden, as a base for its…
18 September 2024
Fasenra approved in the US for eosinophilic granulomatosis with polyangiitis
New indication supported by the MANDARA trial which showed…
The FDA okays AstraZenecas Fasenra for treating adults with eosinophilic granulomatosis with polyangiitis. This is the second approved indication for…
…
Bristol Myers Squibb, AstraZeneca, Eli Lilly and other drug companies have invested some $10 billion on promising cancer technology behind…
Die Astrazeneca-Aktie gerät unter Druck, nachdem die Deutsche Bank Research ihre Einschätzung von "Halten" auf "Verkaufen" herabgestuft und das Kursziel…
AstraZeneca Plc shares are on track for their biggest weekly decline since July 2023, after a disappointing update for the…
FRANKFURT (dpa-AFX Broker) - Deutsche Bank Research hat Astrazeneca von "Hold" auf "Sell" abgestuft…
Wien (www.aktiencheck.de) - Rating-Update:
Hans Engel, Analyst von Erste Group Research, stuft die Aktie von AstraZeneca plc (ISIN: GB0009895292, WKN: 886455,…
FRANKFURT (dpa-AFX Analyser) - Deutsche Bank Research hat Astrazeneca von "Hold" auf "Sell" abgestuft und das Kursziel von 11000 auf…
FRANKFURT (dpa-AFX Analyser) - Deutsche Bank Research hat Astrazeneca von "Hold" auf "Sell" abgestuft und das Kursziel von 11000…
Stockholm (www.aktiencheck.de) - Rating-Update:
Die Analysten von Nordea stufen die Aktie von AstraZeneca plc (ISIN: GB0009895292, WKN: 886455, Ticker-Symbol: ZEG, London…
…
NEW YORK (dpa-AFX Analyser) - Die US-Investmentbank Goldman Sachs hat die Einstufung für Astrazeneca mit einem Kursziel von 15914 Pence…
Blue chips dragged by AstraZeneca, Apple iPhone 16 met with a shrug…
The FTSE 100 dipped on Tuesday as AstraZeneca weighed on the index after announcing disappointing developments for a lung cancer…
AstraZeneca Plc has strong compliance policies in China and is working closely with authorities following the detention of several employees…
AstraZeneca shares fell more than 5% Tuesday morning, the biggest one-day drop in seven months, after the British pharmaceutical giant…
AstraZeneca shares down on disappointing drug trial results…
FTSE 100 falls as AstraZeneca weighs; slowing wage growth cements rate cut bets…
European shares hold ground as AstraZeneca drags, tech shares rise…
FTSE 100 falls by 70 points AstraZeneca off 3% JD Sports leads footsie risers 4.01pm: FTSE 100 flounders The FTSE 100…
FTSE 100 falls by 72 points AstraZeneca off 3% JD Sports leads footsie risers 3.30pm: FTSE 100 hits intraday lows Londons…
FTSE 100 falls by 37 points AstraZeneca off nearly 5% UK jobs data mixed 11.59am: iPhone 16 met with relative indifference…
FTSE 100 falls by 43 points AstraZeneca off nearly 5% JD Sports leads footsie risers 2.51pm: Nasdaq rallies The Nasdaq 100…
FTSE 100 falls by 35 points AstraZeneca off nearly 5% UK jobs data mixed 11.02am: AstraZeneca the biggest FTSE faller of…
Daiichi Sankyo Co. shares drop as much as 10.4% on Tuesday, the most since Aug. 5, after its lung cancer…
…
NEW YORK (dpa-AFX Analyser) - Die US-Bank JPMorgan hat Astrazeneca mit einem Kursziel von 14000 Pence auf "Overweight" belassen. Auf…
NEW YORK (dpa-AFX Analyser) - Die US-Bank JPMorgan hat Astrazeneca mit einem Kursziel von 14000 Pence auf "Overweight" belassen. Auf…
Some employees of British pharmaceutical giant AstraZeneca have been detained by police in China as part of an investigation, the…
AstraZeneca PLC (LSE:AZN) shares fell 3.5% after it confirmed that five current and former employees in China are being held by…